Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4081742
Reference Type
Book/Book Chapter
Title
Chapter 9: Liver and Pancreas
Author(s)
Greaves, P
Year
2012
Publisher
Elsevier Science
Location
Amsterdam, Netherlands
Book Title
Histopathology of preclinical toxicity studies: Interpretation and relevance in drug safety evaluation
Page Numbers
433–535
Language
English
DOI
10.1016/B978-0-444-53856-7.00009-9
Relationship(s)
is a chapter of
2919080
Histopathology of preclinical toxicity studies: Interpretation and relevance in drug safety evaluation
Abstract
The purpose of this chapter is to discuss the importance of the pathologic alterations that can be induced by drugs in the liver of laboratory animals and their implication for hepatic toxicity in patients. It describes anatomy and physiology of the liver of the laboratory species in some detail and discusses how these may differ from humans. Drug-induced hepatic alterations described include changes to hepatic weight, hypertrophy, hyperplasia, storage disorders, pathology of the bile duct and gallbladder as well as the frequently occurring neoplasms in the rodent liver and their implications for human therapy. The chapter also describes a similar range of changes that can be seen in the exocrine pancreas and the endocrine alterations in the islets of Langerhans.
Edition
4th
ISBN
9780444538567
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity